Correlation Between Novocure and Cigna Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novocure and Cigna Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novocure and Cigna Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novocure and Cigna Corp, you can compare the effects of market volatilities on Novocure and Cigna Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novocure with a short position of Cigna Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novocure and Cigna Corp.

Diversification Opportunities for Novocure and Cigna Corp

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Novocure and Cigna is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Novocure and Cigna Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cigna Corp and Novocure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novocure are associated (or correlated) with Cigna Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cigna Corp has no effect on the direction of Novocure i.e., Novocure and Cigna Corp go up and down completely randomly.

Pair Corralation between Novocure and Cigna Corp

Given the investment horizon of 90 days Novocure is expected to generate 1.83 times more return on investment than Cigna Corp. However, Novocure is 1.83 times more volatile than Cigna Corp. It trades about 0.02 of its potential returns per unit of risk. Cigna Corp is currently generating about -0.37 per unit of risk. If you would invest  2,985  in Novocure on October 3, 2024 and sell it today you would lose (5.00) from holding Novocure or give up 0.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Novocure  vs.  Cigna Corp

 Performance 
       Timeline  
Novocure 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Novocure are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental indicators, Novocure reported solid returns over the last few months and may actually be approaching a breakup point.
Cigna Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cigna Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Novocure and Cigna Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novocure and Cigna Corp

The main advantage of trading using opposite Novocure and Cigna Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novocure position performs unexpectedly, Cigna Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cigna Corp will offset losses from the drop in Cigna Corp's long position.
The idea behind Novocure and Cigna Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes